REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Penta Pharma Zrt. (Hungary)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Penta Pharma Zrt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Penta Pharma Zrt. is an enterprise in Hungary, with the main office in Csomad. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. The company was established on June 20, 2021. It currently has a total number of 1 (2024) employees. From the latest financial highlights, Penta Pharma Zrt. reported a net sales revenue increase of 7.38% in 2023. Over the same period, its total assets decreased by 16.29%. In 2023, Penta Pharma Zrt.’s net profit margin decreased by 3.15%.

Headquarters
Jozsef Attila utca 73.
Csomad; Pest; Postal Code: 2161

Contact Details: Purchase the Penta Pharma Zrt. report to view the information.

Basic Information
Total Employees:
Purchase the Penta Pharma Zrt. report to view the information.
Outstanding Shares:
Purchase the Penta Pharma Zrt. report to view the information.
Registered Capital:
Purchase the Penta Pharma Zrt. report to view the information.
Financial Auditors:
Purchase the Penta Pharma Zrt. report to view the information.
Incorporation Date:
June 20, 2021
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Penta Pharma Zrt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
7.38%▲
Total operating revenue
5.24%▲
Operating profit (EBIT)
-19.88%▼
EBITDA
-19.46%▼
Net Profit (Loss) for the Period
-40.87%▼
Total assets
-16.29%▼
Total equity
-9.79%▼
Operating Profit Margin (ROS)
-2.08%▼
Net Profit Margin
-3.15%▼
Return on Equity (ROE)
-8.43%▼
Debt to Equity Ratio
-22.52%▼
Quick Ratio
-0.56%▼
Cash Ratio
0.03%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo